These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 9864893
21. Making the transition from oral to insulin therapy. Riddle MC. Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549 [Abstract] [Full Text] [Related]
24. [Type 2 diabetes: practical guide for starting ambulatory insulin therapy]. Pernet A, Gheno N. Rev Med Suisse; 2006 May 31; 2(68):1453-4, 1456-8,1460-1. PubMed ID: 16783990 [Abstract] [Full Text] [Related]
25. Noninjectable methods of insulin administration. Cernea S, Raz I. Timely Top Med Cardiovasc Dis; 2006 Nov 01; 10():E29. PubMed ID: 17136235 [Abstract] [Full Text] [Related]
26. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes. Garg S, Kelly WC, Garg S. Expert Rev Med Devices; 2008 Mar 01; 5(2):113-23. PubMed ID: 18331174 [Abstract] [Full Text] [Related]
27. [Insulin treatment in type 2 diabetes]. Birkeland KI. Tidsskr Nor Laegeforen; 2006 Mar 23; 126(7):919-20. PubMed ID: 16554885 [No Abstract] [Full Text] [Related]
28. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Pham DQ, Cohen H, Chu V. J Clin Pharmacol; 2007 Jul 23; 47(7):890-903. PubMed ID: 17585117 [Abstract] [Full Text] [Related]
31. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin. Diabetes Forecast; 2008 Jan 23; 61(1):RG11-4. PubMed ID: 18290288 [No Abstract] [Full Text] [Related]